An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

As we move forward into a new era of ophthalmology, with increased options to address vision issues, patient expectations are ...

The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...

Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients ...

Extended depth of focus contact lenses improved near to intermediate vision while maintaining far vision, leading to higher ...

Living along coastal areas in the United States that had higher levels of microplastics in the ocean was strongly associated ...

Women who reported a greater number of symptoms during perimenopause also reported poorer cognitive function and more mild ...

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

The deportation of immigrant workers and restrictions on immigration could negatively affect health care in the United States ...

Oncology practices must address barriers related to technology and workflow to successfully implement a system to collect patient-reported outcomes, according to a viewpoint paper published in JAMA ...

In the 2024 update of The Lancet Commission’s position on dementia care, a panel of experts identified 14 modifying risk ...

Miebo produced substantial symptom relief in patients with dry eye disease during the first day and succeeding weeks of ...